Cefazolin (B Braun Medical)

头孢唑林 (贝朗医疗美国有限公司)

Report date: 2025/07/03 20:00:09

Base Information

Drug NameCefazolin (B Braun Medical)
Drug Alias NameCefazolin 3gm for Injection USP and Dextrose Injection USPCefazolin in a DUPLEX ContainerDUPLEX dual-chamber IV bag systemCefazolin 1 GM InjectionCefazolin 2 GM Injection
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsAcute bacterial skin and skin structure infectionsEndocarditisProstatitis +[10] 
Global Approved IndicationsAcute bacterial skin and skin structure infectionsEndocarditisProstatitis +[9] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2000/07/27
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesB Braun Medical Inc
China Registration ClassN/A

Develop Information

Active CompaniesB Braun Medical
Inactive CompaniesB Braun Medical Inc
Active IndicationsAcute bacterial skin and skin structure infectionsEndocarditisProstatitis +[9] 
Inactive IndicationsInfections

Other Information

ATC CodeN/A
Related LinksN/A